ArticlePediatric cardiology2017
Early Complications After Percutaneous Closure of Atrial Septal Defect in Infants with Procedural Weight Less than 15 kg.
Article in Pediatric cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 33 citations in OpenAlex.
- ASD Diameter Indexed to Total Septal Length Outperforms Expert Opinion in Predicting Future Candidacy for Percutaneous ASD Closure.Pediatric cardiology · 2026Article
- Transcatheter Closure of Complex Atrial Septal Defects in Children: A Single-Center Experience.Journal of clinical practice and research · 2025Article
- Percutaneous atrial septal defect closure in limited-resource setting: a decade-long experience from Ethiopia.Frontiers in cardiovascular medicine · 2025Article
- Can Artificial Intelligence Revolutionize the Diagnosis and Management of the Atrial Septal Defect in Children?Diagnostics (Basel, Switzerland) · 2024Review
- Outcomes Following Closure of Secundum Atrial Septal Defect in Children ≤ 15 kg in a French Tertiary Centre.Journal of clinical medicine · 2023Article
- Successful Transjugular Percutaneous Atrial Septal Defect Closure in a Dextrocardia Patient with Kartagener's Syndrome, Situs Inversus, Interrupted Inferior Vena Cava, and Bilateral Superior Vena Cava.Anatolian journal of cardiology · 2023Article
- Case report: Early thrombosis in left atrial during transcatheter closure of ASD in a child with favorable outcome after use of GPIIb/IIIa receptor antagonist and heparin.Frontiers in pediatrics · 2023Article
- Review
- Association between the Use of Diuretics and Size Reduction in Pediatric Atrial Septal Defect.Korean circulation journal · 2021Article
- Percutaneous closure of atrial septal defect in patients under 15 kilograms using balloon assisted technique. Case reportArchivos de cardiologia de Mexico · 2020Article
- Predictors of the Need for an Atrial Septal Defect Closure at Very Young Age.Frontiers in cardiovascular medicine · 2019Article
- The efficacy and safety of using amplatzer for transcatheter closure of atrial septal defect in small children with less than 10 kg.ARYA atherosclerosis · 2019Article
- State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart.Interventional cardiology clinics · 2019Review
- Impact of hospital volume on outcomes of percutaneous ASD/PFO closure in pediatric patients.World journal of pediatrics : WJP · 2018Article
- Transcatheter device closure of atrial septal defects: more to think about than just closing the hole.Current opinion in cardiology · 2018Review
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial septal defect (ASD) is the most common congenital cardiac lesion accounting for 10-15% of all cardiac malformations. In the majority of cases, the secundum type of the ASD is closed percutaneously in the catheterization laboratory. Although transcatheter closure of ASD is considered safe and effective in pediatric patients, there are limited data regarding the efficacy and safety of device ASD closure in smaller infants. The aim of this study was to determine risk of complications within 72 h following device closure of ASD in children of body weight <15 kg compared to larger children. Overall 252 children who underwent transcatheter closure of ASD at Children's Heart Centre in Lund, Sweden, between 1998 and 2015 were included. Data regarding demographics, comorbidity and complications occurring during and after device procedure until discharge were retrieved from the hospital's databases. Echocardiographic data were obtained from the digital and videotape recordings. Nearly half of the study cohort (n = 112; 44%) had a procedural weight <15 (median 11.3) kg with a median procedural age of 2.02 years. Among this study group, 22 (9%) children had post-procedural in-hospital complications, of which 16 (7%) were considered as major and six (2%) considered as minor. No deaths occurred. There was no significant difference in of the occurrence of major or minor complications between the two groups (p = 0.32). Larger ASD was more often associated with minor complications, OR 1.37 (95% CI 0.99-1.89), which most often consisted of transient arrhythmias during or after the procedure. Percutaneous ASD device closure can be performed safely in low-weight infants with a risk of post-procedural in-hospital complications comparable to larger/older children. Nevertheless, careful considerations of the indications to device closure is needed, particularly in children with larger ASD, as recommended by the current international guidelines for ASD closure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.